Beihai Gofar Chuanshan Biological Co., Ltd. (SHA:600538)

Market Cap	3.20B +19.6%
Revenue (ttm)	316.06M -9.5%
Net Income	-76.82M
EPS	-0.14
Shares Out	524.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,683,401
Average Volume	13,350,786
Open	5.94
Previous Close	6.10
Day's Range	5.91 - 6.21
52-Week Range	4.32 - 7.70
Beta	0.19
RSI	40.79
Earnings Date	Apr 18, 2026

About SHA:600538

Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly operated and franchised chain drugstores. It also provides pearl eye drops, pearl powder, and pearl layer powder under the Haibao brand; weichangning ...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1993
• Employees: 453
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600538

Financial Performance

In 2024, SHA:600538's revenue was 340.47 million, a decrease of -7.77% compared to the previous year's 369.15 million. Losses were -93.85 million, 14.0% more than in 2023.